Three months after initiating layoffs, hitting pause on a planned COPD study and terminating an agreement with the COPD Foundation, Kaleido Biosciences is now shutting down. On Friday, the biotech’s board voted to “immediately wind-down and cease all of the Company’s ongoing operations,” according to an SEC filing. CEO Daniel Menichella, CFO William Duke, and … Continue reading Flagship-backed microbiome company Kaleido Biosciences shuts down